Decoy Therapeutics
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -1 | -1 | -1 | -1 |
EBITDA | -872 | -956 | -1,708 | -1,462 |
EBIT | -873 | -957 | -1,709 | -1,463 |
Net Income | -873 | -957 | -1,709 | -1,463 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -1,646 | -862 | -1,181 | -742 |
Cash | 4,809 | 794 | 1,798 | 2,434 |
Basic Shares | 481 | 141 | 110 | 96 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $1,840 |
Gross Profit | -4 | -10 | -6 | 1,821 |
EBITDA | -5,571 | -12,532 | -31,601 | -12,749 |
EBIT | -5,575 | -12,542 | -31,607 | -12,768 |
Net Income | -5,575 | -12,542 | -31,607 | -12,768 |
Net Change In Cash | 0 | 0 | 0 | 1,840 |
Free Cash Flow | -4,525 | -12,846 | -17,595 | -10,200 |
Cash | 2,434 | 5,899 | 12,106 | 29,214 |
Basic Shares | 64 | 27 | 17 | 13 |
